These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 21242533)
1. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach. Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533 [TBL] [Abstract][Full Text] [Related]
2. Long-term safety and efficacy data on botulinum toxin type A: an injection for sialorrhea. Chan KH; Liang C; Wilson P; Higgins D; Allen GC JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):134-8. PubMed ID: 23429943 [TBL] [Abstract][Full Text] [Related]
3. [Efficacy and safety of botulinum toxin in the treatment of sialorrhea in children with neurological disorders]. García Ron A; Miranda MC; Garriga Braun C; Jensen Verón J; Torrens Martinez J; Diez Hanbino MP An Pediatr (Barc); 2012 Oct; 77(4):289-91. PubMed ID: 22652186 [No Abstract] [Full Text] [Related]
4. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms. Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339 [TBL] [Abstract][Full Text] [Related]
6. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy? Vaile L; Finlay F Arch Dis Child; 2006 Oct; 91(10):862-3. PubMed ID: 16990361 [No Abstract] [Full Text] [Related]
7. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists. Shariat-Madar B; Chun RH; Sulman CG; Conley SF Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558 [TBL] [Abstract][Full Text] [Related]
8. Ultrasound-Guided Botulinum Toxin Type A Salivary Gland Injection in Children for Refractory Sialorrhea: 10-Year Experience at a Large Tertiary Children's Hospital. Lungren MP; Halula S; Coyne S; Sidell D; Racadio JM; Patel MN Pediatr Neurol; 2016 Jan; 54():70-5. PubMed ID: 26706481 [TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630 [No Abstract] [Full Text] [Related]
10. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections. Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin injections for children with excessive drooling. Hassin-Baer S; Scheuer E; Buchman AS; Jacobson I; Ben-Zeev B J Child Neurol; 2005 Feb; 20(2):120-3. PubMed ID: 15794177 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B; Aslami B; Backes H Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [TBL] [Abstract][Full Text] [Related]
13. Salivary botulinum toxin injection may reduce aspiration pneumonia in neurologically impaired children. Faria J; Harb J; Hilton A; Yacobucci D; Pizzuto M Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2124-8. PubMed ID: 26478107 [TBL] [Abstract][Full Text] [Related]
14. Secondary effects of botulinum toxin injections into salivary glands for the management of pediatric drooling. Reid SM; Walstab JE; Chong D; Westbury C; Reddihough DS J Craniofac Surg; 2013 Jan; 24(1):28-33. PubMed ID: 23348253 [TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin for the treatment of sialorrhea: a meta-analysis. Vashishta R; Nguyen SA; White DR; Gillespie MB Otolaryngol Head Neck Surg; 2013 Feb; 148(2):191-6. PubMed ID: 23112272 [TBL] [Abstract][Full Text] [Related]
16. Does Botulinum neurotoxin type A treatment for sialorrhea change oral health? Tiigimäe-Saar J; Taba P; Tamme T Clin Oral Investig; 2017 Apr; 21(3):795-800. PubMed ID: 27114092 [TBL] [Abstract][Full Text] [Related]
17. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands. Taib BG; Williams SP; Sood S; Ung K; Nixon PP; Sharma R Br J Oral Maxillofac Surg; 2019 Jun; 57(5):442-448. PubMed ID: 31010597 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study. Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374 [TBL] [Abstract][Full Text] [Related]
19. Ultrasound-guided, intraglandular injection of botulinum toxin A in children suffering from excessive salivation. Gerlinger I; Szalai G; Hollódy K; Németh A J Laryngol Otol; 2007 Oct; 121(10):947-51. PubMed ID: 17391573 [TBL] [Abstract][Full Text] [Related]
20. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis. Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]